Stem cells and cancer: treatment resistance and novel therapeutic targets Rob Clarke
Stem cells and cancer: treatment resistance and novel therapeutic targets Rob Clarke Manchester, UK Q-CROC, Montreal, 6 th November, 2010. Cancer. Potential conflict of interests. Paid consultant for Epistem, AstraZeneca, Vertex and Pfizer
494 views • 35 slides